Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
May 12, 2023 at 09:17 am EDT
Share
Microbio Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 380.65 million compared to TWD 394.15 million a year ago. Revenue was TWD 387.59 million compared to TWD 402.02 million a year ago.
Net loss was TWD 105.97 million compared to net income of TWD 807.24 million a year ago. Basic loss per share from continuing operations was TWD 0.1916 compared to basic earnings per share from continuing operations of TWD 1.4416 a year ago. Diluted loss per share from continuing operations was TWD 0.1916 compared to diluted earnings per share from continuing operations of TWD 1.4416 a year ago.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 
